Chiesi Company Profile

What is the competitive landscape for CHIESI

CHIESI has fifteen approved drugs.

There are fifty-three US patents protecting CHIESI drugs.

Summary for Chiesi

US Patents:	53
Tradenames:	16
Ingredients:	10
NDAs:	15
Patent Litigation for Chiesi:	See patent lawsuits for Chiesi

Drugs and US Patents for Chiesi

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chiesi	CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	019734-005	Nov 7, 2008		DISCN	Yes	No	8,455,524
Chiesi	MYCAPSSA	octreotide acetate	CAPSULE, DELAYED RELEASE;ORAL	208232-001	Jun 26, 2020		RX	Yes	Yes	8,329,198		Y
Chiesi	FERRIPROX	deferiprone	TABLET;ORAL	212269-001	May 19, 2020		RX	Yes	Yes	10,940,116		Y
Chiesi	CARDENE SR	nicardipine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020005-002	Feb 21, 1992		DISCN	Yes	No
Chiesi	CARDENE	nicardipine hydrochloride	INJECTABLE;INJECTION	019734-001	Jan 30, 1992	AP	RX	Yes	No
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-004	Apr 23, 2015		RX	Yes	Yes	7,932,268

Expired US Patents for Chiesi

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-006	Apr 23, 2015	10,555,938
Chiesi	ZYFLO CR	zileuton	TABLET, EXTENDED RELEASE;ORAL	022052-001	May 30, 2007	5,422,123
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-001	Dec 21, 2012	10,555,938
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-002	Dec 21, 2012	9,433,617
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-002	Dec 21, 2012	9,265,758
Chiesi	JUXTAPID	lomitapide mesylate	CAPSULE;ORAL	203858-003	Dec 21, 2012	10,016,404

Paragraph IV (Patent) Challenges for CHIESI drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Injection	2.5 mg/mL, 10 mL Ampoules		2006-12-27
	Inhalation Solution	300 mg/4 mL		2017-08-31
	Injection	0.1 mg/mL, 200 mL and0.2mg/mL, 200 mL		2013-06-20
	Tablets	500 mg		2016-01-29

International Patents for Chiesi Drugs

Country	Patent Number	Estimated Expiration
Denmark	2504012
New Zealand	734894
Croatia	P20200445
Eurasian Patent Organization	033227
Mexico	2008013407
Russian Federation	2015112963

Supplementary Protection Certificates for Chiesi Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1725234	2014C/002	Belgium		PRODUCT NAME: LOMITAPIDE ET TOUTE FORME THERAPEUTIQUEMENT EQUIVALENTE TELLE QUE PROTEGEE PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/13/851/001 20130805
1725234	C 2014 003	Romania		PRODUCT NAME: LOMITAPIDA SAU O SARE ACCEPTABILA FARMACEUTIC SAU PIPERIDIN-N-OXIDUL ACESTEIA; NATIONAL AUTHORISATION NUMBER: EU/1/13/851/001-003; DATE OF NATIONAL AUTHORISATION: 20130731; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/13/851/001-003; DATE OF FIRST AUTHORISATION IN EEA: 20130731
3089735	C03089735/01	Switzerland		PRODUCT NAME: GLYCOPYRRONIUMBROMID, FORMOTEROLFUMARAT-DIHYDRAT UND BECLOMETASONDIPROPIONAT; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67223 06.05.2020
1758555	641	Finland
2515855	314 50020-2017	Slovakia		PRODUCT NAME: GLYKOPYRONIUMBROMID/FORMOTEROL VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM/- BEKLOMETAZONDIPROPIONAT; REGISTRATION NO/DATE: EU/1/17/1208 20170717
2515855	2018/002	Ireland		PRODUCT NAME: A COMBINATION OF GLYCOPYRRONIUM BROMIDE, FORMOTEROL OR A SALT THEREOF AND BECLOMETASONE DIPROPIONATE.; REGISTRATION NO/DATE: EU/1/17/1208 20170717

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Chiesi